News

Organoids Market is Segmented by Type (Stem Cell Source, Tumor Cell Source), by Application (Biopharmaceutical Companies, Academics and Research Institutes, Hospital).
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...
Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...
The Catholic Medical Center of Catholic University has taken a meaningful first step in the treatment of osteoarthritis.
In a heart-warming encounter, 12-year-old Thalassemia survivor Pratham, from Bikaner, met the man who gave him a second ...
Hayley Jankowski has been interested in biomedical research since her freshman year of high school. Now, the Rowan University ...
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...
Diagnosed with thalassemia at 7 months, Pratham was cured after 7 years via a stem cell transplant from a stranger. His story highlights the urgent need for more bone marrow donors in India.